Search Results 1701-1710 of 13088 for transexamic

  1. A Trial Investigating the Safety, Tolerability and Efficacy of TransCon PTH in Adults With Hypoparathyroidism - Mayo Clinic

    About this study. To assess the effectiveness of daily TransCon PTH on serum and calcium levels and active vitamin D and calcium doses at 4 weeks of ...

  2. A Study to Assess the Efficacy and Safety of Risankizumab in Subjects With Moderately to Severely Active Crohn's Disease Who Failed Prior Biologic Treatment - Mayo Clinic

    The objective of Study M15-991 is to evaluate the efficacy and safety of risankizumab versus placebo during induction therapy in subjects with moderately to ...

  3. Bringing Mayo Clinic knowledge and expertise to Carteret Health Care

    William "Harvey" case, chief executive officer, Carteret Health Care, shares the value of the clinical collaboration with Mayo Clinic is keeping more ...

  4. Fitusiran (subcutaneous route) - Side effects & dosage - Mayo Clinic

    Fitusiran injection is used to prevent or decrease the frequency of bleeding episodes in patients with hemophilia A or B with or without factor VIII or IX ...

  5. Betibeglogene autotemcel (intravenous route) - Side effects & uses - Mayo Clinic

    Betibeglogene autotemcel injection is used to treat beta thalassemia in patients who need regular red blood cell (RBC) transfusions. This medicine is to be ...

  6. A Study to Assess Epicardial Delivery of XC001 Gene Therapy for Refractory Angina Coronary Treatment (The EXACT Trial) - Mayo Clinic

    The primary purpose of this trial is to determine the safety of XC001 (AdVEGFXC1) in patients who suffer from angina caused by coronary artery disease and have ...

  7. Patient Stories - Eduardo E. Benarroch, M.D. - Mayo Clinic

    Fuel groundbreaking medical research! ... Your donation powers the future of medicine and helps save lives. Help Fund Research.

  8. Insulin Regulation of Lipolysis and Lipolysis Proteins - Mayo Clinic

    About this study. The purpose of this study is to determine whether impaired insulin-induced suppression of lipolysis (as measured by IC50) is related to ...

  9. Moxetumomab pasudotox-tdfk (intravenous route) - Side effects & uses - Mayo Clinic

    Moxetumomab pasudotox-tdfk injection is used to treat hairy cell leukemia that has worsened or cannot be completely removed in patients who have had at least ...

  10. Publications

    Publications. Pulukuri SV, Fagle TR, Trujillo-Rodriguez D, van Amerongen S, Bernick C, Geda YE, Wethe JV, Peskind ER, Katz DI, Alosco ML, Palmisano JN, ...